David Nikodem is the founder of AltheaDx. AltheaDx has raised $40M in total funding. Latest round: Series D. Based in San Diego, United States.
David Nikodem is the CEO of AltheaDx, a San Diego-based commercial stage molecular diagnostics company specializing in pharmacogenomics with a focus on mental health. The company offers molecular diagnostics, biomarker discovery, and immunological assay development. AltheaDx has raised a total of $40.3 million USD in funding.
Full founder directory · Investor directory · Company funding database · Fundraising library